Where now for colony-stimulating factors?

This publication has 12 references indexed in Scilit:

• Hematopoietic growth factors for the treatment of severe chronic neutropenia
  The International Journal of Cell Cloning, 1995
• Increased Circulating Cytokines, Cytokine Antagonists, And E-Selectin After Intravenous Administration Of Endotoxin In Humans
  The Journal of Infectious Diseases, 1995
• Optimization of peripheral blood stem cell collection
  Current Opinion in Hematology, 1995
• A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells
  Blood, 1994
• Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin
  The Lancet, 1994
• Role of Granulocyte Colony-Stimulating Factor in the Immune Response to Acute Bacterial Infection in the Nonneutropenic Host: An Overview
  Clinical Infectious Diseases, 1994
• Quality of life of patients with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor
  JAMA, 1993
• Granulocyte and granulocyte-macrophage colony-stimulating factors
  The Lancet, 1993
• A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia
  Blood, 1993
• Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia
  Blood, 1990